Cargando…
OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission
Autores principales: | Lingappa, JR, Hughes, JP, Donnel, D, Baeten, JM, Mullins, JI, Campbell, MS, Gray, GE, Essex, M, Farquhar, C, Rees, H, Wald, A, Corey, L, Celum, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767532/ http://dx.doi.org/10.1186/1742-4690-6-S3-O12 |
Ejemplares similares
-
OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial
por: Rolland, M, et al.
Publicado: (2009) -
Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk
por: Lingappa, Jairam R., et al.
Publicado: (2010) -
OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector
por: Baden, LR, et al.
Publicado: (2009) -
OA03-06 LB. Unique stimulatory properties of myeloid dendritic cells in individuals with "elite" HIV-1 control
por: Huang, J, et al.
Publicado: (2009) -
Using Plasma Viral Load to Guide Antiretroviral Therapy Initiation to Prevent HIV-1 Transmission
por: Murnane, Pamela M., et al.
Publicado: (2012)